Disfunción Eréctil

Acemannan, the principal sulfated polysaccharide of Aloe vera, demonstrates direct inhibitory effects against HSV-1 in vitro by interfering with viral attachment to host cell glycosaminoglycans. It also promotes wound healing via fibroblast stimulation. It is considered the primary bioactive contributing to aloe vera's documented anti-HSV activity.

Aloe vera has antiviral, anti-inflammatory, and wound-healing properties documented in laboratory, animal, and limited clinical studies for herpes infections. Compounds including acemannan inhibit HSV-1 replication. A double-blind RCT (Phytomedicine 1999) found 0.5% aloe extract cream improved healing in genital herpes. Animal studies confirmed delayed blister progression in HSV lesions. Evidence for herpes labialis specifically is more limited than for genital herpes.

Bee propolis has been evaluated in multiple RCTs for herpes labialis and shown to be at least equivalent, and in several trials superior, to topical acyclovir 5% cream in reducing healing time and symptom scores. A 2026 meta-analysis confirmed propolis and honey showed better healing outcomes than acyclovir. The most studied formulation is propolis special extract GH 2002 at 0.5% concentration.

Docosanol (n-docosanol, 1-docosanol) is the only FDA-approved non-prescription topical agent for cold sores (herpes labialis). A multicenter randomized placebo-controlled trial demonstrated that 10% docosanol cream reduced mean healing time from 7.3 to 5.7 days compared to placebo. It acts by incorporating into host cell plasma membranes to block viral fusion and entry, a mechanism distinct from nucleoside analog antivirals.

Glycyrrhetinic acid, the aglycone metabolite of glycyrrhizin from licorice root, directly inhibits HSV replication and inactivates HSV particles. Anti-inflammatory mechanisms via inhibition of lipoxygenase, cyclooxygenase, and protein kinase C reduce lesion-associated inflammation. Its derivative carbenoxolone has documented clinical effectiveness specifically against recurrent herpes labialis.

Glycyrrhizin, the principal triterpenoid of licorice root, inhibits HSV replication, irreversibly inactivates herpes virus particles in vitro, and in vivo increased survival rates of HSV-1-infected mice by over 2-fold. Limited clinical evidence supports topical glycyrrhizin-containing preparations for herpes labialis; its derivative carbenoxolone has documented clinical efficacy against recurrent herpes labialis.

Medical-grade honey (kanuka, manuka) has been evaluated in clinical RCTs for herpes labialis. A large RCT (BMJ Open 2019, n=952) found kanuka honey was as effective as topical acyclovir. A clinical study found medical-grade honey (L-Mesitran) outperformed conventional cold sore treatments in healing time and symptom relief. A 2026 meta-analysis confirmed honey alongside propolis showed superior healing to acyclovir.

L-lysine is among the most researched natural agents for cold sore prevention. Multiple double-blind RCTs demonstrate that doses ≥1 g/day significantly reduce recurrence frequency and severity of herpes simplex labialis. The mechanism involves competitive antagonism of arginine, which HSV-1 requires for replication.

Lactoferrin, a glycoprotein in milk and secretions, inhibits HSV-1 infection by competing with viral glycoprotein C for cell-surface heparan sulfate binding sites, blocking the initial adsorption step. This mechanism was confirmed in PubMed-indexed mechanistic studies using GAG-deficient cell lines. It is identified among natural products with anti-HSV evidence in a 2023 narrative review.

Lemon balm (Melissa officinalis) is the most extensively studied herbal treatment for cold sores. Multiple double-blind, placebo-controlled RCTs demonstrate that topical 1% standardized lemon balm cream significantly reduces healing time, lesion size, blister count, and symptom severity. A 2025 systematic review confirmed lemon balm as among topical herbal interventions with demonstrated benefits for herpes labialis.

Glycyrrhizin and glycyrrhetinic acid demonstrate direct antiviral activity against herpes simplex virus (HSV-1/2) in in vitro and animal studies. Human clinical studies of IV glycyrrhizin for herpes family viruses (including shingles/VZV and Kaposi's sarcoma-associated herpesvirus in hepatitis B patients) showed symptom improvement. Topical glycyrrhetinic acid preparations are used for herpes/cold sores in several European countries.

Melaleuca alternifolia essential oil (tea tree oil) has documented in vitro antiherpetic activity against HSV-1 and HSV-2 via direct virucidal action before cell adsorption. Small clinical observations support reduction in cold sore healing time. It is included within the scope of herbal interventions reviewed in the 2025 systematic review of herbal medicine for herpes labialis.

Monolaurin (glycerol monolaurate), derived from lauric acid, disrupts lipid membranes of enveloped viruses including HSV-1 and HSV-2, inactivating viral particles in vitro. Laboratory studies confirm monolaurin inactivates HSV in cell cultures by interfering with viral envelope integrity. A PMC-published literature review confirmed in vitro antiviral activity against HSV; human RCTs for herpes labialis are lacking.

A randomized double-blind clinical trial comparing 2% topical OLE cream versus 5% acyclovir cream for HSV-1 labialis found OLE superior in healing time and symptom resolution. Oleuropein inhibits HSV-1 replication in vitro by stimulating PKR phosphorylation. This represents the strongest direct clinical evidence for OLE in cold sores.

Propolis is a resinous bee product with multiple RCTs demonstrating efficacy against herpes labialis at least equivalent, and often superior, to acyclovir 5% cream. A 2025 systematic review and a 2026 meta-analysis confirmed propolis as one of the strongest herbal interventions for herpes labialis, with demonstrated shorter healing times and better symptom resolution compared to acyclovir in several trials.

Quercetin demonstrates significant anti-HSV-1 activity in vitro via suppression of TLR-3-dependent inflammatory signaling and inhibition of HSV proteins (gD, ICP0) and viral genes (ICP0, UL13, UL52). It is identified as an AMPK activator with anti-HSV activity similar to resveratrol in cell culture. Evidence is primarily in vitro; no large clinical trials specific to herpes labialis have been published.

Resveratrol has been comprehensively reviewed as an anti-HSV nutraceutical agent. Multiple in vitro studies demonstrate marked inhibition of HSV-1 and HSV-2 replication via AMPK activation and NF-κB suppression. It showed activity against acyclovir-resistant HSV strains. A 2018 PMC review synthesized available evidence for its mechanisms and anti-HSV efficacy.

A double-blind, comparative randomized trial in 149 patients found that topical rhubarb-sage cream was as effective as acyclovir cream for herpes labialis (oral cold sores), with mean healing time of 6.7 days versus 6.5 days for acyclovir. The combination is superior to sage cream alone.

Tea tree oil (Melaleuca alternifolia) demonstrates significant in vitro antiherpetic activity against HSV-1 and HSV-2, primarily via direct virucidal action before host cell adsorption, confirmed in plaque reduction assays. Small clinical observations document reduction of cold sore duration from ~7 days to ~3 days with topical application. It is recognized in herbal medicine literature for antiviral activity against herpesviruses.

Vitamin C (ascorbic acid) has documented antiviral activity against HSV-1 in vitro and small clinical evidence supporting reduction of cold sore healing time as a topical paste. It is combined with vitamin E and honey in medical-grade formulations (L-Mesitran) shown in a clinical study to outperform conventional cold sore treatments. It is identified in the Viruses 2023 narrative review among natural products with evidence for controlling HSV.

Vitamin E has clinical documentation for topical cold sore pain relief and accelerated healing. A clinical case series found near-immediate pain relief and markedly accelerated healing with topical vitamin E oil applied to cold sores. Incorporated into medical-grade honey formulations (L-Mesitran), it is part of a combination shown in a clinical study to outperform conventional cold sore treatments. A 2023 narrative review identifies it among natural products with HSV evidence.

Topical zinc formulations (zinc oxide, zinc sulfate) have been evaluated in multiple RCTs and shown to modestly reduce the duration and severity of cold sore outbreaks. Zinc salts applied to herpes lesions decrease viral load and improve healing rates. Zinc gluconate is listed in the US Homeopathic Pharmacopoeia with an OTC indication for cold sores, and topical zinc oxide is referenced in authoritative cold sore treatment reviews.